Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age

被引:8
|
作者
Patel, Dhaval [1 ]
Kitahara, Cari M. [2 ]
Park, Yikyung [3 ,4 ]
Liao, Linda M. [3 ]
Linet, Martha [3 ]
Kebebew, Electron [1 ]
Nilubol, Naris [1 ]
机构
[1] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Div Canc Epidemiol & Genet, Radiat Epidemiol Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, NIH, Bethesda, MD 20892 USA
[4] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA
关键词
CYCLOOXYGENASE-2; EXPRESSION; PAPILLARY CARCINOMA; COX-2; ASSOCIATION; HEALTH; METAANALYSIS; ASPIRIN; IMPACT; RISK;
D O I
10.1089/thy.2015.0198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cyclooxygenase (COX-2) has been associated with tumor growth and metastasis in several cancers, including thyroid cancer. For this reason, several investigators have studied COX-2 inhibitors in preclinical models of thyroid cancer and found antineoplastic effects. Thus, the primary aim of this study was to assess if the use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of thyroid cancer. A second aim of the study was to determine additional risk or protective factors for thyroid cancer. Methods: Three large prospective population-based studies (the NIH-AARP Diet and Health Study; the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; and the U.S. Radiologic Technologists Study) were pooled to investigate the association between self-reported frequency of aspirin and nonaspirin NSAID use one year prior to baseline (no use, 2/week, >2-6/week, and 7/week) and subsequent risk of thyroid cancer. A Cox regression proportional hazard model was used to estimate aggregated hazard ratios (HR) adjusted for cohort, sex, race/ethnicity, weight, smoking status, and alcohol intake. Results: There were 388,577 participants in the pooled cohort, with 481 cases of thyroid cancer. No significant risk reduction was observed with regular use of nonaspirin NSAIDs (HR=1.14 [confidence interval (CI) 0.84-1.55]), and/or regular use of aspirin (HR=1.06 [CI 0.82-1.39]). The multivariate regression analysis confirmed as previously reported in the literature that female sex, obesity class I (body mass index [BMI]=30-34.99kg/m(2)), and obesity class II (BMI=35-35.99kg/m(2)) were independently associated with an increased thyroid cancer risk. Current smoking status and moderate and excessive alcohol use were also confirmed as independent risk factors associated with a reduced thyroid cancer risk. Conclusions: Neither nonaspirin NSAIDs nor aspirin use is associated with a reduced risk of thyroid cancer. Women and obesity are associated with an increased risk of thyroid cancer, whereas smoking and alcohol use are associated with decreased risk of thyroid cancer.
引用
收藏
页码:1355 / 1362
页数:8
相关论文
共 50 条
  • [1] Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis
    Hu, Huabin
    Xie, Yangchun
    Yang, Guorong
    Jian, Chengzhu
    Deng, Yanhong
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2014, 23 (01) : 62 - 68
  • [2] The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
    van Staalduinen, Jente
    Frouws, Martine
    Reimers, Marlies
    Bastiaannet, Esther
    van Herk-Sukel, Myrthe P. P.
    Lemmens, Valery
    de Steur, Wobbe O.
    Hartgrink, Henk H.
    van de Velde, Cornelis J. H.
    Liefers, Gerrit-Jan
    BRITISH JOURNAL OF CANCER, 2016, 114 (09) : 1053 - 1059
  • [3] Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
    Tian, Wenjing
    Zhao, Yashuang
    Liu, Shengyuan
    Li, Xin
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (04) : 288 - 298
  • [4] Meta-Analysis on the Association Between Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Risk
    Xu, Jiali
    Yin, Zhiqiang
    Gao, Wen
    Liu, Lingxiang
    Wang, Rongsheng
    Huang, Puwen
    Yin, Yongmei
    Liu, Ping
    Yu, Rongbin
    Shu, Yongqian
    CLINICAL LUNG CANCER, 2012, 13 (01) : 44 - 51
  • [5] Use of nonsteroidal anti-inflammatory drugs in the older adult
    Fowler, Terri O.
    Durham, Catherine O.
    Planton, Jonathan
    Edlund, Barbara J.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (08) : 414 - 423
  • [6] Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease
    Heleniak, Zbigniew
    Cieplinska, Magdalena
    Szychlinski, Tomasz
    Rychter, Dymitr
    Jagodzinska, Kalina
    Kos, Alicja
    Kuzmiuk, Izabela
    Tylicka, Marzena Jakimowicz
    Tylicki, Leszek
    Rutkowski, Bolesaw
    Debska-Slizien, Alicja
    JOURNAL OF NEPHROLOGY, 2017, 30 (06) : 781 - 786
  • [7] Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients
    Ou, Shuo-Ming
    Chen, Yung-Tai
    Chao, Pei-Wen
    Lee, Yi-Jung
    Liu, Chia-Jen
    Yeh, Chiu-Mei
    Chen, Tzeng-Ji
    Chen, Tzen-Wen
    Yang, Wu-Chang
    Li, Szu-Yuan
    KIDNEY INTERNATIONAL, 2013, 84 (01) : 198 - 205
  • [8] Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
    Liao, Linda M.
    Vaughan, Thomas L.
    Corley, Douglas A.
    Cook, Michael B.
    Casson, Alan G.
    Kamangar, Farin
    Abnet, Christian C.
    Risch, Harvey A.
    Giffen, Carol
    Freedman, Neal D.
    Chow, Wong-Ho
    Sadeghi, Shahram
    Pandeya, Nirmala
    Whiteman, David C.
    Murray, Liam J.
    Bernstein, Leslie
    Gammon, Marilie D.
    Wu, Anna H.
    GASTROENTEROLOGY, 2012, 142 (03) : 442 - U85
  • [9] Association of Nonsteroidal Anti-inflammatory Drug Use With Stroke Among Dialysis Patients
    Hsu, Chih-Cheng
    Chang, Yu-Kang
    Hsu, Yueh-Han
    Lo, Yu-Ru
    Liu, Jia-Sin
    Hsiung, Chao A.
    Tsai, Hui-Ju
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (03): : 400 - 409
  • [10] Nonsteroidal Anti-inflammatory Drug Use in Horses
    Knych, Heather K.
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2017, 33 (01) : 1 - +